Cargando…

Survival and Side Effects in Non-Small Cell Lung Cancer Patients Treated With Combination of Chemotherapy and Conformal Radiotherapy

BACKGROUND: Combined modality therapy is standard of care for patients with inoperable locally advanced non-small cell lung cancer (NSCLC), however, insufficient data exist regarding what chemoradiotherapy combination will be the gold standard. AIM: The study aimed to compare the survival impact and...

Descripción completa

Detalles Bibliográficos
Autor principal:	Crvenkova, Simonida
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Republic of Macedonia 2018
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311484/ https://www.ncbi.nlm.nih.gov/pubmed/30607184 http://dx.doi.org/10.3889/oamjms.2018.490

Ejemplares similares

Prognostic Factors and Survival in Non-Small Cell Lung Cancer Patients Treated with Chemoradiotherapy
por: Crvenkova, Simonida
Publicado: (2015)

The survival outcomes and prognosis of stage IV non-small-cell lung cancer treated with thoracic three-dimensional radiotherapy combined with chemotherapy
por: Su, ShengFa, et al.
Publicado: (2014)

EP06.01-013 Differences of Oncology Treatment for Lung Cancer Patients in Pandemic COVID-19 Year: Our Clinical Experience
por: crvenkova, s., et al.
Publicado: (2022)

The analysis of prognostic factors affecting post-radiation acute reaction after conformal radiotherapy for non-small cell lung cancer
por: Spych, Michał, et al.
Publicado: (2010)

Conformity Index and Homogeneity Index of the Postoperative Whole Breast Radiotherapy
por: Petrova, Deva, et al.
Publicado: (2017)

Stereotactic body radiotherapy improves the survival of patients with oligometastatic non‐small cell lung cancer
por: Ouyang, Wen, et al.
Publicado: (2019)

Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapy
por: Polee, M B, et al.
Publicado: (2003)

Involved-Field Radiotherapy versus Elective Nodal Irradiation in Combination with Concurrent Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Prospective Randomized Study
por: Chen, Ming, et al.
Publicado: (2013)

A phase I study of combination chemotherapy with gemcitabine and oral UFT for advanced non-small cell lung cancer
por: Seto, T, et al.
Publicado: (2002)

Prognostic implication of PD‐L1 polymorphisms in non‐small cell lung cancer treated with radiotherapy
por: Kang, Min Kyu, et al.
Publicado: (2021)

Comparison of survival rates between 3D conformal radiotherapy and intensity-modulated radiotherapy in patients with stage III non-small cell lung cancer
por: Kong, Moonkyoo, et al.
Publicado: (2016)

Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects
por: Dearnaley, D P, et al.
Publicado: (2005)

Better Survival with Three-Dimensional Conformal Radiotherapy Than with Conventional Radiotherapy for Cervical Cancer: A Population-Based Study
por: Hsieh, Chen-Hsi, et al.
Publicado: (2013)

Evaluation of radiotherapy combined with targeted therapy and concurrent radiotherapy, chemotherapy in the treatment of Non-Small Cell Lung Cancer with brain metastasis
por: Sun, Yanfeng, et al.
Publicado: (2020)

Serum proteomic test in advanced non-squamous non-small cell lung cancer treated in first line with standard chemotherapy
por: Grossi, F, et al.
Publicado: (2017)

Prognostic score models for survival of nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy and chemotherapy
por: Zeng, Lei, et al.
Publicado: (2015)

Differential expression of hypoxia-inducible factor 1α in non-small cell lung cancer and small cell lung cancer
por: Karetsi, Eleni, et al.
Publicado: (2012)

EGFR‐mutated stage IV non‐small cell lung cancer: What is the role of radiotherapy combined with TKI?
por: Liu, Bailong, et al.
Publicado: (2021)

Survival outcome according to KRAS mutation status in newly diagnosed patients with stage IV non-small cell lung cancer treated with platinum doublet chemotherapy
por: Brady, Anna K., et al.
Publicado: (2015)

Adjuvant chemotherapy, not radiotherapy, prolongs survival for node-negative non–small cell lung cancer with positive surgical margins
por: Ashrafi, Arman, et al.
Publicado: (2023)

Accelerated regrowth of non-small-cell lung tumours after induction chemotherapy
por: El Sharouni, S Y, et al.
Publicado: (2003)

Impact of peritoneal cytology on survival of endometrial cancer patients treated with surgery and radiotherapy
por: Tebeu, P M, et al.
Publicado: (2003)

Combination Chemotherapy with Cyclophosphamide, Vincristine, Cisplatin and Etoposide(COPE) Combined with Radiotherapy for Small Cell Lung Cancer
por: Nam, Yong Jin, et al.
Publicado: (1995)

Clinical Effect of Radiotherapy Combined with Chemotherapy for Non-Surgical Treatment of the Esophageal Squamous Cell Carcinoma
por: Chen, Hongmin, et al.
Publicado: (2018)

Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of-life benefits in advanced non-small-cell lung cancer
por: von Plessen, C, et al.
Publicado: (2006)

Predictive factors associated with prolonged survival in patients with advanced non-small-cell lung cancer (NSCLC) treated with gefitinib
por: Satouchi, M, et al.
Publicado: (2007)

Three-Dimensional Conformal Radiotherapy for Hepatocellular Carcinoma in Patients Unfit for Resection, Ablation, or Chemotherapy: A Retrospective Study
por: Kouloulias, Vassilis, et al.
Publicado: (2013)

The effectiveness and side effects of conformal external beam radiotherapy combined with high-dose-rate brachytherapy boost compared to conformal external beam radiotherapy alone in patients with prostate cancer
por: Smolska-Ciszewska, Beata, et al.
Publicado: (2015)

Preoperative induction chemotherapy with cisplatin and irinotecan for pathological N(2) non-small cell lung cancer
por: Date, H, et al.
Publicado: (2002)

Lung cancer survival in England: trends in non-small-cell lung cancer survival over the duration of the National Lung Cancer Audit
por: Khakwani, A, et al.
Publicado: (2013)

Prognostic Factors in the Survival of Patients Diagnosed with Primary Non-Metastatic Osteosarcoma with a Poor Response to Neoadjuvant Chemotherapy
por: Júnior, Rosalvo Zósimo Bispo, et al.
Publicado: (2009)

Standard radiotherapy but not chemotherapy impairs systemic immunity in non-small cell lung cancer
por: Talebian Yazdi, Mehrdad, et al.
Publicado: (2016)

Prognosis of non-small cell lung cancer patients with bone oligometastases treated concurrently with thoracic three-dimensional radiotherapy and chemotherapy
por: Ouyang, Wei-Wei, et al.
Publicado: (2014)

Non-small cell lung cancer in never smokers: a clinical entity to be identified
por: Santoro, Ilka Lopes, et al.
Publicado: (2011)

Procalcitonin Level in Non-Small Cell Lung Cancer Patients among Indonesian Population
por: Soeroso, Noni Novisari, et al.
Publicado: (2018)

Sequential chemotherapy followed by radical thoracic radiotherapy (50 Gy in 25 fractions) in limited stage small cell lung cancer
por: Iqbal, Muhammad Shahid, et al.
Publicado: (2020)

A nomogram for predicting overall survival in patients with resected non-small cell lung cancer treated with chemotherapy
por: Zeng, Yuan, et al.
Publicado: (2021)

A meta-analysis of the therapeutic effect of gefitinib combined with chemotherapy and chemotherapy alone in treating non-small cell lung cancer
por: Zhao, Qingda, et al.
Publicado: (2020)

Survival and prognostic factors of non-small cell lung cancer patients with postoperative locoregional recurrence treated with radical radiotherapy
por: Ma, Li, et al.
Publicado: (2017)

Front-line paclitaxel and irinotecan combination chemotherapy in advanced non-small-cell lung cancer: a phase I–II trial
por: Stathopoulos, G P, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_kcth9md9h09gsduoc79b83s3kf